Frank Lee, Forma CEO (File photo)
December 19, 2019 09:35 AM ESTUpdated 04:31 PM
Financing

For­ma Ther­a­peu­tics bounces back from Cel­gene fall­out with $100 mil­lion Se­ries D

Jason Mast

Editor

Last we heard about For­ma Ther­a­peu­tics’ fund­ing was in March, when they were lay­ing off em­ploy­ees as long­time part­ner and bene­fac­tor Cel­gene — then in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times